Senior insider sale
XENON PHARMACEUTICALS INC. — senior position signals high conviction
$640.6K
10K shares
What this filing means
GANNON STEVEN plans to sell 10K shares of XENON PHARMACEUTICALS INC. valued at approximately $640.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001193125-26-349336
10K
Shares to sell
$640.6K
Approx. market value
23.64K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of Options
Cash
5/12/2026
3.50KExercise of Options
Cash
5/14/2025
5.14KOpen Market Purchase
Cash
8/11/2017
15KTotal acquired23.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/12/2026 | Exercise of Options Cash | 3.50K | — |
5/14/2025 | Exercise of Options Cash | 5.14K | — |
8/11/2017 | Open Market Purchase Cash | 15K | — |
| Total | 23.64K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$640.6K
8/11/2026
Total
Units
10K
Value
$640.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 10K | $640.6K | NASDAQ | Planned |
| Total | 10K | $640.6K | ||